Related by context. All words. (Click for frequent words.) 75 refractory acute promyelocytic 72 refractory myeloma 71 Ribavirin causes 71 tumors GIST 71 refractory chronic lymphocytic 70 carcinoma mCRC 70 leukemia AML 69 CYT# potent vascular disrupting 69 refractory NSCLC 69 refractory cutaneous T 69 mitoxantrone plus 69 metastatic GIST 68 damage cirrhosis liver 68 Systemic lupus erythematosus SLE 68 neutropenia dehydration dyspnea 68 leukemia CLL 68 relapsed refractory multiple myeloma 67 Acute myeloid leukemia 67 Cutaneous T 67 recurrent glioblastoma multiforme 67 Myelofibrosis 67 refractory multiple myeloma 67 pyrexia mucositis sepsis febrile 67 stage IIIb IV 67 HBeAg negative 67 Amgen Neulasta R 67 dasatinib Sprycel ® 67 vascular occlusive diseases 66 refractory acute myeloid 66 relapsed Acute Myeloid 66 immune thrombocytopenic purpura 66 Chronic lymphocytic leukemia CLL 66 relapsed MM 66 Carcinoid tumors 66 cutaneous T 66 Sezary syndrome 66 Acute Myelogenous Leukemia AML 66 systemic anaplastic large 66 non splenectomized 66 gastrointestinal stromal 66 juvenile myelomonocytic leukemia 66 Acute myelogenous leukemia 66 advanced hepatocellular carcinoma 66 recurrent NSCLC 65 relapsing remitting MS RRMS 65 idiopathic thrombocytopenic purpura ITP 65 metastatic kidney 65 acute GvHD 65 Brentuximab Vedotin SGN 65 Amgen Neulasta ® 65 unresectable tumors 65 refractory indolent non 65 Acute Myeloid Leukaemia 65 LymphoStat B belimumab 65 Lactic acidosis 65 Soft Tissue Sarcoma 65 myelodysplastic myeloproliferative diseases 65 whose tumors overexpress 65 cell lymphoma CTCL 65 myelodysplastic syndrome MDS 65 SPRYCEL ® 65 8mg/kg 65 EGFR expressing mCRC 65 myocardial infarction ventricular fibrillation 65 metastatic renal cell 65 MCyR 65 Relapsed Refractory 65 Relapsing remitting MS 65 irinotecan containing 65 Peginterferon alfa 2b 65 pancreatic NET 65 hypereosinophilic syndrome 65 paclitaxel cisplatin 65 Dementia Related Psychosis 65 Ph + acute lymphoblastic 65 metastatic bladder 65 receiving INTRON 65 peripheral sensory neuropathy 65 gastrointestinal stromal tumor GIST 65 anthracycline taxane 65 hepatorenal syndrome 65 NMIBC 65 non metastatic osteosarcoma 65 Refractory Hodgkin Lymphoma 65 relapsed leukemia 65 advanced metastatic renal 65 complement inhibitor eculizumab 65 hematologic disorders 65 subependymal giant cell 65 refractory CLL 65 Kit CD# positive 65 pancytopenia 65 cirrhosis liver failure 64 ACTEMRA TM 64 metastatic gastric 64 leukemia ALL 64 haematologic 64 metastatic renal 64 skeletal metastases 64 cell acute lymphoblastic 64 Leukemias 64 Chronic lymphocytic leukemia 64 mCRC acneform rash 64 erlotinib Tarceva ® 64 Infusion Reactions Severe 64 chronic granulomatous disease 64 Anthracycline 64 acute myeloid 64 Hepatocellular Carcinoma HCC 64 chemotherapy cisplatin 64 delayed onset CINV 64 Philadelphia Chromosome Positive 64 cisplatin chemotherapy 64 refractory peripheral T 64 Decitabine 64 novel VDA molecule 64 Diffuse Large B 64 acute porphyria 64 myelofibrosis polycythemia vera 64 Friedreich Ataxia FRDA 64 chronic myeloid 64 Navelbine ® 64 gastrointestinal stromal tumors GIST 64 BCG refractory carcinoma 64 blastic phase 64 relapsed multiple myeloma 64 leukaemias 64 decompensated liver disease 64 chronic eosinophilic leukemia 64 refractory AML 64 carcinoma HCC 64 adjunctive ABILIFY 64 Glioblastoma multiforme GBM 64 adriamycin 64 lymphoma CTCL 64 PEGINTRON TM 64 Infusion reactions 64 unresectable locally advanced 64 rheumatoid arthritis psoriatic arthritis 64 Renal impairment 64 candidates Azedra TM 64 lymphocytosis 64 TNF antagonist 64 Follicular Lymphoma 64 mcg kg REBETOL 64 severe malignant osteopetrosis 64 FOLFIRI alone 64 cisplatin gemcitabine 64 gastrointestinal stromal tumors 64 hyperphenylalaninemia HPA due 64 Acute Myeloid Leukaemia AML 64 MAGE A3 ASCI 64 TTF Therapy 64 Invasive fungal infections 64 hematologic toxicity 64 primary immunodeficiency PI 64 deletion 5q 64 taxane chemotherapy 64 GI GVHD common 64 posterior uveitis 64 gastrointestinal mucositis 64 included exfoliative dermatitis 64 galiximab 64 BENLYSTA belimumab 63 placebo dexamethasone 63 neuroendocrine cancers 63 severe hypersensitivity reactions 63 C1 INH deficiency 63 biologic DMARD 63 imatinib Gleevec ® 63 plus prednisone prednisolone 63 cytopenias 63 infliximab monotherapy 63 fungoides 63 Myelodysplastic syndromes 63 Azacitidine 63 lymphoid blast 63 refractory gout 63 IMiDs 63 Fludara ® 63 progesterone receptor negative 63 kidney urologic 63 multiple myeloma MM 63 heavily pretreated 63 naïve HCV 63 refractory Hodgkin lymphoma 63 refractory Ph + 63 Known hypersensitivity 63 metastatic malignant 63 Vidaza ® 63 papillary renal cell carcinoma 63 familial amyloidotic polyneuropathy FAP 63 HBeAg negative patients 63 alpha interferons 63 systemic fungal infections 63 refractory indolent NHL 63 autoantibody positive 63 basal cell carcinoma BCC 63 CTAP# Capsules 63 systemic autoimmune 63 indolent follicular non 63 chronic immune thrombocytopenic 63 lenalidomide Revlimid R 63 cyclophosphamide methotrexate 63 R sorafenib tablets 63 LHRH analogues 63 swallowing radioactive iodine 63 VELCADE melphalan 63 severe hepatomegaly 63 brand ciclesonide HFA 63 Metastatic breast cancer 63 Adjuvant chemotherapy 63 either acutely decompensated 63 GRNOPC1 contains 63 remission induction 63 EXJADE 63 Acute Myeloid Leukemia AML 63 Cariprazine 63 invasive candidiasis 63 genetic lysosomal storage 63 metastatic colorectal 63 non hodgkin lymphoma 63 CYP#A# substrate 63 chemosensitizer 63 unresectable recurrent 63 biliary tract cancer 63 steroid refractory ulcerative 63 refractory CTCL 63 ara C 63 vinca alkaloids 63 sorafenib tablets 63 myalgia arthralgia 63 Complicated Skin 63 R Saizen R 63 refractory chronic myeloid 63 esthesioneuroblastoma rare form 63 chronic idiopathic thrombocytopenic purpura 63 receiving XGEVA 63 Vitrasert ® 63 Malignant mesothelioma 63 FUSILEV enhances 63 cyclophosphamide chemotherapy 63 Acute Bacterial Sinusitis ABS 63 metastatic renal cell carcinoma 63 relapsed acute myelogenous 63 Glioblastoma Multiforme 63 ® lenalidomide 63 immune idiopathic thrombocytopenic 63 Wafer polifeprosan 63 Toxicities 63 smoldering myeloma 63 underwent surgical resection 62 paroxysmal nocturnal hemoglobinuria PNH 62 demonstrated antitumor activity 62 hepatic metastases 62 sarcoma melanoma 62 Chronic myeloid leukemia CML 62 thrombocytopenia neutropenia 62 Fludarabine 62 vWD 62 pediatric acute lymphoblastic 62 pegylated interferon alpha 62 oral JAK#/JAK# inhibitor 62 Myelodysplastic Syndrome 62 post herpetic neuralgia PHN 62 adalimumab Humira 62 receiving VELCADE 62 HER2 positive metastatic breast 62 KRAS mutant tumors 62 hyperplasia BPH 62 rheumatoid arthritis RA psoriatic 62 chlorambucil 62 metastatic neuroendocrine tumors 62 essential thrombocythemia ET 62 acetonide FA 62 Atypical Hemolytic Uremic Syndrome 62 Severe Sepsis 62 generalized edema 62 K ras mutations 62 arthritis PsA 62 refractory acute lymphoblastic 62 novel emulsion formulation 62 opioid induced constipation OIC 62 hepatitis C HCV 62 Dermatologic toxicities 62 candidemia 62 mRCC 62 Amrubicin 62 Chronic Myelogenous Leukemia CML 62 histologic subtype 62 psoriatic arthritis PsA 62 IV metastatic melanoma 62 purpura ITP 62 alfa 2a 62 postoperative pathology 62 chronic metabolic acidosis 62 HBeAg positive patients 62 polyneuropathy HIV DSP 62 recurrent malignant glioma 62 mycosis fungoides 62 neutropenia thrombocytopenia 62 relapsed acute lymphoblastic 62 hematological diseases 62 lupus erythematosus 62 hematological malignancy 62 metastatic malignant melanoma 62 dacarbazine DTIC 62 LHRH receptor positive 62 Jevtana 62 metastatic pancreatic 62 Hormone Refractory Prostate Cancer 62 antiangiogenesis therapies 62 relapsing multiple sclerosis 62 radiation chemoradiation 62 MKC# MT 62 dirucotide MBP# 62 anaplastic astrocytoma 62 Chronic HCV infection 62 Gleevec resistant 62 TRIOLEX HE# APOPTONE HE# 62 myeloproliferative diseases 62 achieved ACR# 62 chronic ITP patients 62 EGFr expressing mCRC 62 B CLL 62 Newly Diagnosed Chronic Myeloid 62 anthracycline containing 62 plus dexamethasone 62 castration resistant hormone refractory 62 stage IIIB 62 Lupus nephritis 62 epithelial ovarian 62 AA Amyloidosis 62 non squamous 62 BARACLUDE ® 62 acute leukemias 62 bone marrow reticulin deposition 62 hematopoietic cancers 62 receiving highly emetogenic 62 targeted immunotherapies 62 dasatinib Sprycel 62 commercialize deforolimus 62 hepatic failure 62 lymphocytic leukemia 62 erythematosus 62 Severe Primary IGFD 62 oral vancomycin 62 induced macular edema 62 Albuferon TM 62 oropharyngeal candidiasis OPC 62 superficial basal cell carcinoma 62 TELINTRA 62 conventional DMARDs 62 Hereditary angioedema HAE 62 ribavirin therapy 62 d l leucovorin 62 lymphoma leukemia 62 taxane chemotherapy administered 62 TTR amyloidosis 62 seminoma 62 refractory Hodgkin 62 monoclonal antibody conjugated 62 FOLFOX6 62 Waldenstrom macroglobulinemia 62 Squamous 62 irinotecan doxorubicin oxaliplatin paclitaxel 62 malignant neoplasms 62 trastuzumab Herceptin ® 62 achieved CCyR 62 nonmetastatic 62 HER2 overexpression 62 FluCAM arm 62 FLT3 mutations 62 malignant cancerous 61 recurrent glioblastoma 61 Flu Cy 61 lung esophageal 61 indolent NHL 61 4mg/kg 61 herpetic keratitis 61 NAGS deficiency 61 myelodysplastic syndromes MDS 61 nilotinib Tasigna ® 61 reduce serum phosphate 61 recurrent GBM 61 IV NSCLC 61 Acute lymphoblastic leukemia 61 lintuzumab SGN 61 systemic scleroderma 61 leukemia lymphoma multiple myeloma 61 stage IIIB IV 61 Pharmacokinetics PK 61 hepatocellular cancer 61 alpha folate receptor 61 acute HAE attacks 61 fallopian tube carcinoma 61 cetuximab Erbitux R 61 BioMarin develops 61 LymphoStat B TM 61 EGFR mutation positive 61 Irinotecan 61 include Healive TM 61 malignant pleural effusion 61 Castration Resistant Prostate Cancer 61 INSPIRE Trial Phase III 61 myeloproliferative neoplasms 61 fatal hemorrhagic 61 Doxil ® 61 huN# DM1 61 recurrent glioblastoma multiforme GBM 61 prokinetic agent 61 Folfox 61 Combination REOLYSIN R 61 iGVHD 61 Chronic myeloid leukemia 61 myelodysplastic syndromes 61 docetaxel chemotherapy 61 metastatic colorectal carcinoma 61 humans variant Creutzfeldt 61 Chronic Lymphocytic Leukemia CLL 61 Chronic HCV 61 bladder ovarian 61 TMP SMX 61 Annamycin 61 refractory anaplastic astrocytoma 61 tuberous sclerosis TS 61 receiving chemoradiation therapy 61 partial remissions 61 allogeneic bone marrow 61 Dacogen injection 61 Hsp# Inhibitor 61 cytogenetic responses 61 active ankylosing spondylitis 61 evaluating tivozanib 61 pneumocystis carinii pneumonia 61 induce orthostatic hypotension 61 Alemtuzumab 61 5 FU leucovorin 61 completely resected 61 refractory systemic ALCL 61 receptor tyrosine kinase inhibitor 61 atypical hemolytic uremic syndrome 61 alkylating agents 61 metastatic HER2 negative 61 cisplatin resistant 61 endocrine therapies 61 cytogenetic response 61 pegylated interferon alfa 2a 61 refractory PTCL 61 Systemic lupus erythematosus 61 autoimmune disorder characterized 61 Anaplastic 61 Sudhir Agrawal D.Phil 61 combining voreloxin 61 thalassemia sickle cell 61 adult chronic ITP 61 used DNA alkylating 61 del 5q MDS 61 achieved sustained virologic 61 Cell Non Hodgkin 61 delayed CINV 61 Follicular lymphoma 61 refractory metastatic 61 Host Disease GvHD 61 Angioedema 61 Myelodysplastic Syndrome MDS 61 ALN HPN 61 hormone refractory metastatic prostate 61 metabolic alkalosis 61 alpha1 antitrypsin deficiency 61 metaglidasen 61 diseases chronic granulomatous 61 hyperammonemia 61 atypical Hemolytic Uremic Syndrome 61 oncologic diseases 61 via intradermal injections 61 R lenalidomide 61 cancer mCRC 61 Recombinant interferon alpha 61 plus prednisone 61 symptomatic BPH 61 cytotoxic therapy 61 treating sarcoma testicular 61 Nexavar sorafenib 61 PEGylated anti 61 vaginal candidiasis 61 mycophenolic acid 61 alkylating agent 61 investigational monoclonal antibody 61 resistant hormone refractory 61 prior chemotherapy regimens 61 ketoacidosis hyperosmolar coma 61 KETEK 61 nonalcoholic steatohepatitis NASH 61 FOLOTYN ® 61 severe hepatic dysfunction 61 Tamibarotene 61 Tarceva TM 61 Newly Diagnosed Multiple Myeloma 61 Vidaza azacitidine 61 systemic ALCL 61 Darinaparsin 61 TO AVOID PREGNANCY WHILE 61 Zevalin R Ibritumomab 61 receiving immunosuppressive therapy 61 remitting MS 61 hypercalcemia 61 calcineurin inhibitor 61 biochemical relapse 61 dysplastic lesions 61 Tarceva erlotinib 61 TEAEs 61 follicular lymphomas 61 primary generalized tonic 61 HeFH 61 Hurthle cell 61 constipation OIC 61 Idiopathic pulmonary fibrosis 61 sarcomatoid 61 post transplant lymphoproliferative 61 extrapyramidal symptoms EPS 61 Leukopenia neutropenia 61 lymphoblastic leukemia 61 Bronchiectasis 61 advanced carcinoid 61 Mantle Cell Lymphoma 61 acute renal insufficiency 61 Fludara 61 including eniluracil ADH 61 adjunctive placebo 61 fluoropyrimidine oxaliplatin 61 bortezomib refractory 61 Mg Usa 61 virus HCV protease inhibitor 61 5-fluorouracil/leucovorin 61 oral clodronate 61 partial onset seizures 61 ULTRAM ER 61 MCSP respectively 61 Chronic ITP 61 locoregional 61 Renal Cell Carcinoma 60 adrenocortical cancer 60 Basal cell 60 Chronic Lymphocytic Leukemia 60 gemcitabine Gemzar ® 60 serologically active systemic lupus 60 gastrointestinal disorders ATI 60 taxane therapy 60 receiving VICTRELIS 60 efalizumab 60 Bullous 60 Acute lymphocytic leukemia 60 modified glutathione analog 60 overactive bladder syndrome 60 recurrent genital herpes 60 bacterial foodborne illness 60 manufactures minimally invasive 60 smoldering multiple myeloma 60 weekly intravenous infusions 60 dexamethasone Decadron 60 telaprevir dosed 60 ENL recurrence 60 Temporal lobe epilepsy 60 intravesical infusion therapy 60 upon rechallenge 60 targeted anticancer biopharmaceuticals 60 paraganglioma 60 systemic lupus erythematosus psoriasis 60 intravenous RSD# 60 forodesine 60 PEGylated Fab fragment 60 Gleevec imatinib 60 diarrhea headache nausea 60 Pemetrexed 60 ZACTIMA TM ZD# 60 Erythropoietic therapies may 60 bone marrow suppression 60 corticosteroids immunoglobulins 60 gastrointestinal GI motility disorders 60 HGS ETR1 mapatumumab 60 immune thrombocytopenic purpura ITP 60 cutaneous T cell 60 Idiopathic Pulmonary Fibrosis IPF 60 torsade de pointes 60 riociguat 60 basiliximab 60 hepatitis B HBV 60 rufinamide 60 Peg IFN 60 S. aureus bloodstream infections 60 Pulmonary Arterial Hypertension PAH 60 splenectomized 60 Cojocaru correspondent 60 lumiliximab 60 postherpetic neuralgia PHN 60 cell carcinoma RCC 60 CHOP chemotherapy 60 gastrointestinal stromal tumors GISTs 60 hepato renal syndrome 60 vinorelbine 60 precursor acute lymphoblastic 60 BUPHENYL 60 events thrombocytopenia neutropenia 60 idarubicin 60 opsoclonus myoclonus syndrome 60 Chronic Myeloid Leukemia 60 chronic thromboembolic pulmonary 60 steroid refractory 60 rituximab refractory 60 chronic HBV infection 60 anaplastic astrocytoma AA 60 Opportunistic infections 60 coinfected patients 60 Ovitrelle R Serostim 60 venous stasis ulcers 60 Febrile neutropenia 60 Omacetaxine 60 hepatitis C genotype 60 Acute Myelogenous Leukemia 60 2 methoxyestradiol 60 SJIA 60 interferon ribavirin 60 alvespimycin 60 transfusion syndrome 60 Gleevec Glivec 60 esophageal candidiasis 60 bone spurs bulging 60 panitumumab Vectibix 60 potentially hepatotoxic 60 relapsed CLL 60 acute myelogenous leukemia AML 60 CIN3 60 neuro inflammatory 60 chronically immunosuppressed solid 60 malignant neoplasm 60 Malignant Melanoma 60 Hodgkin lymphoma HL 60 GW# [003] 60 recurrent colorectal cancer 60 cirrhosis scarring 60 Paraplatin ® 60 urinary bladder wall 60 leukemia aplastic anemia 60 immunodeficiency disorders 60 Voreloxin 60 dermatologic reactions 60 tumor lysis syndrome 60 goserelin 60 TNF Blockers 60 neurological manifestations 60 de novo kidney transplant 60 doxorubicin cyclophosphamide 60 PROCRIT ® 60 PEG INTRON R 60 thetreatment 60 RoACTEMRA 60 substantially excreted 60 hepatocellular carcinomas 60 tumor angiogenesis inhibitors 60 PLX STROKE targeting 60 Severe cutaneous 60 malignant pleural mesothelioma 60 headache abdominal pain 60 estramustine 60 histologically active 60 Insegia 60 Improved Progression 60 metastatic RCC 60 metastatic carcinoma 60 situ CIS 60 malignant ascites 60 gemcitabine cisplatin 60 muscular dystrophy cystic fibrosis 60 Cimzia ® certolizumab pegol 60 medically inoperable 60 EGFR HER2 60 Stage IIB 60 Vandetanib 60 osteolytic bone disease 60 ovarian lung 60 Adenoviruses usually cause 60 C1 inhibitor deficiency 60 hemolytic anemia 60 doxorubicin HCl liposome injection 60 cause cardiac channelopathies 60 Alzheimer disease cognitive impairment 60 SNT-MC#/idebenone 60 non metastatic resectable 60 evaluating picoplatin 60 gastrointestinal stromal tumor 60 thalidomide Thalomid 60 vincristine doxorubicin 60 transplantation HCT 60 membranous nephritis 60 ovarian breast 60 Gemzar ® 60 phase III isavuconazole 60 Evoltra ® 60 BARACLUDE R 60 PNH patients 60 interferon gamma 1b 60 lymphomas leukemias 60 castrate resistant 60 Gel repository corticotropin injection 60 anthracyclines taxanes 60 Leukemia AML 60 vitreoretinal disorders 60 alcoholic hepatitis 60 leukemia multiple myeloma 60 Bronchopulmonary Dysplasia 60 Meets Primary Endpoint 60 visilizumab 60 Neovascular 60 PEGylated interferon beta 1a 60 progressive neurodegenerative disorder 60 Mitoxantrone 60 Naive Patients 60 intracranial hemorrhage ICH 60 HLA DR2 60 Host Disease 60 dysentery bursitis 60 nonsmall cell lung cancer 60 small lymphocytic lymphoma 60 primary hypercholesterolemia 60 invasive aspergillosis 60 subcutaneous immunoglobulin 60 GvHD 60 pancreatic carcinoma 60 unresectable 60 PORxin TM platforms 60 metastatic hormone refractory 60 vandetanib 60 receiving TNF blockers 60 ceroid lipofuscinosis NCL 60 refractory DLBCL 60 metastatic carcinoid 60 haloperidol Haldol 60 non alcoholic steatohepatitis 60 nutlin 3a 60 pancreatic neuroendocrine tumors 60 cystic fibrosis chronic pancreatitis 60 myelogenous leukemia 60 pediatric malignancies 60 Paraplatin ® carboplatin 60 musculoskeletal metabolic 60 somatostatin analog 60 PAOD 60 Telintra 60 clodronate 60 Investigational Treatment 60 cervical carcinoma 60 Myelodysplasia 60 Abiraterone Acetate 60 anthracycline chemotherapy 60 imatinib Gleevec 60 debilitating complication 60 stage IIIb 60 MELAS 60 Frankfurter Wertpapierbörse Amtlicher Markt 60 superficial bladder cancer 60 System IPSS 60 docetaxel Taxotere ® 60 gemcitabine carboplatin 60 Papillary 60 Pegylated Interferon 60 tumor xenograft models 60 imatinib resistant 60 Treatment Shows Promise 59 phase Ph + 59 By Breffni O'Rourke 59 severe oral mucositis 59 ® bortezomib 59 non myeloid malignancies 59 Squamous cell 59 relapsed ovarian cancer 59 Epratuzumab 59 unresectable hepatocellular carcinoma HCC 59 Nexavar tablets 59 leukemia CML 59 Ovarian cysts 59 Psychotic depression 59 nicardipine 59 Syndrome LEMS 59 metastatic castration resistant 59 Gliomas 59 Neovascular Age Related Macular 59 Renal Cell Carcinoma RCC 59 hormone refractory 59 metformin accumulation 59 Temodar ® 59 Pegloticase 59 severe renal impairment 59 dopaminergic therapy 59 eosinophilic asthma 59 vinorelbine tartrate 59 Hypotension 59 Lupus Nephritis 59 hereditary antithrombin deficiency 59 metastatic dermatofibrosarcoma protuberans DFSP 59 Prodarsan R 59 refractory metastatic colorectal cancer 59 CIMZIA TM certolizumab pegol 59 aflibercept VEGF Trap 59 High Dose quadruples 59 Atopic eczema 59 CLL SLL 59 Aflibercept 59 invasive fungal infections 59 haemolytic uraemic syndrome 59 prostate adenocarcinoma 59 Colorectal Cancer CRC 59 infantile spasms IS 59 intravascular hemolysis 59 unprovoked seizures 59 Herceptin trastuzumab 59 Myeloma Patients 59 moderate renal impairment 59 Arzerra ofatumumab 59 induce remission 59 hypercalcaemia 59 PNP inhibitor 59 idiopathic thrombocytopenic purpura 59 weekly subcutaneous injections 59 cytomegalovirus CMV retinitis 59 epithelial tumors 59 hormone deprivation 59 Class IIIB IV 59 cervical lymph nodes 59 chronic leukemias 59 5 fluorouracil leucovorin 59 ZOLINZA 59 nucleoside naive 59 elevated plasma concentrations 59 paroxysmal nocturnal hemoglobinuria 59 recurrent metastatic 59 necrotizing pneumonia 59 splenectomized patients 59 malignancy HCM 59 HIV HCV coinfected 59 ATC ovarian cancer 59 ribavirin RBV 59 overt hepatic encephalopathy HE 59 Ectopic pregnancy 59 Plaque psoriasis 59 HCV NS5B polymerase 59 antiepileptic medications 59 Alkeran 59 elevated ALT 59 VEGFR2 inhibitor 59 autoimmune encephalitis 59 Research www. elsevier.com 59 Lambert Eaton Myasthenic 59 paclitaxel chemotherapy 59 tipranavir ritonavir 59 Malignant Glioma 59 squamous cell carcinoma SCC 59 commercializes oncology 59 secondary hyperparathyroidism 59 FOLFOX chemotherapy 59 Severe hypersensitivity reactions 59 lymphoma multiple myeloma 59 relapsed follicular lymphoma 59 Advanced Melanoma 59 palonosetron hydrochloride Injection Dacogen 59 acute peptic ulcer 59 DEB# 59 Myelodysplastic Syndromes MDS 59 adverse cytogenetics 59 azacitidine 59 EGFr expressing metastatic colorectal 59 PCNSL 59 plus methotrexate 59 peripheral arterial occlusive disease 59 prednisone prednisolone 59 underwent resection 59 Juvenile Idiopathic Arthritis JIA 59 toenail onychomycosis 59 refractory rituximab naive 59 exocrine pancreatic insufficiency EPI 59 Elotuzumab 59 Vicinium TM 59 pT3 59 trans retinoic acid ATRA 59 mucocutaneous reactions 59 treats paroxysmal nocturnal 59 anemia neutropenia 59 follicular lymphoma FL 59 Medullary thyroid cancer 59 Pegasys peginterferon alfa 2a 59 leukemia myeloma 59 postoperative chemotherapy 59 cytopenia 59 FluCAM 59 interferon alpha IFN alpha 59 anthracycline therapy 59 unknown etiology 59 T Cell Lymphoma 59 CTAP# 59 Major Depressive Disorder MDD 59 inhibit oxidative stress 59 oligodendrogliomas 59 BRAF gene mutations 59 Renal Impairment 59 standard chemotherapy regimens 59 Extensively drug 59 huC# DM4 59 lichen planus 59 mycophenolate mofetil 59 Aviptadil 59 rheumatoid arthritis osteoarthritis ankylosing 59 PR interval prolongation 59 bendamustine 59 glioblastoma multiforme GBM 59 thrombocytopenic 59 myeloproliferative disorders 59 ATTR PN 59 hemophagocytic lymphohistiocytosis 59 BENLYSTA TM 59 diarrhea predominant irritable 59 pediatric Crohn disease 59 imatinib therapy 59 juvenile myoclonic epilepsy 59 protease inhibitor PI 59 nephropathic cystinosis cystinosis 59 immunocompromised transplant 59 NOMID 59 low dose cytarabine 59 Gliadel Wafer 59 bacterial vaginosis BV 59 AA amyloidosis 59 Diabetic Macular Edema 59 chemotherapy induced neutropenia 59 neoadjuvant therapy 59 DOXIL 59 relapsed refractory 59 inherited metabolic diseases 59 Mitomycin C 59 IV melanoma 59 acute promyelocytic leukemia 59 chronic HBV 59 TNF blocker therapy 59 rheumatoid arthritis inflammatory bowel 59 q8h 59 Nilotinib 59 mutated KRAS 59 miconazole MBT 59 Metastatic Colorectal Cancer 59 CIMZIA ™ 59 Immune reconstitution syndrome 59 commercializes innovative biopharmaceuticals 59 differentiated thyroid 59 T#I mutant 59 essential thrombocythemia 59 azacytidine 59 heparin induced thrombocytopenia 59 RhuDex ® 59 HBeAg positive 59 Acute myeloid leukemia AML 59 unresectable stage 59 squamous cell lung cancer 59 CCyR 59 DOXIL ® 59 TORISEL 59 severe neutropenia 59 perioperatively 59 Multidrug resistant TB 59 leukemias lymphomas 59 acute promyelocytic leukemia APL 59 Glioblastoma Multiforme GBM 59 Seliciclib 59 Fingolimod 59 Acute Exacerbations 59 sapropterin dihydrochloride Tablets 59 HIV coinfected 59 steroid refractory GvHD 59 Pneumococcal meningitis 59 TEMODAL 59 testicular tumors 59 Cimzia TM 59 drug DMARD 59 Gleevec imatinib mesylate 59 inhalation anthrax cutaneous anthrax 59 interstitial pneumonitis 59 Pelvic inflammatory 59 SSRI SNRI 59 five MDS subtypes 59 cytoreduction 59 virus HCV infection 59 ovarian endometrial 59 Antitumor activity 59 Acute Promyelocytic Leukemia 59 HER2 negative 59 cilengitide 59 ALT flares 59 Pancreatic neuroendocrine tumors 59 acute mania 59 T#I [002] 59 Solid Tumors criteria